A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals
Identifieur interne : 002962 ( Main/Exploration ); précédent : 002961; suivant : 002963A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals
Auteurs : Peter Schneider [Allemagne] ; Tatjana A. Korolenko [Russie] ; Ulrich Busch [Allemagne]Source :
- Microscopy Research and Technique [ 1059-910X ] ; 1997-02-15.
Abstract
Lysosomotropic agents are selectively taken up into lysosomes following their administration to man and animals [de Duve et al. (1974) Biochem. Pharmacol. 23:2494–2531] The effects of lysosomotropic drugs studied in vivo and in vitro can be used as models of lysosomal storage diseases. These agents include many drugs still used in clinical medicine: aminoglycosides used in antibiotics [Tulkens (1988)]; phenothiazine derivatives; such antiparasitic drugs as chloroquine and suramin; antiinflammatory drugs like gold sodium thiomalate; and cardiotonic drugs like sulmazol [Schneider (1992) Arch. Toxicol. 66:23–33]. Side‐effects to these drugs can be caused by their lysosomotropic properties. In addition to drugs, other compounds to which man and animals are exposed (e.g., metals, cytostatics, vitamins, hormones) are also lysosomotropic. Liver cells, especially Kuppfer cells, are known to accumulate lysosomotropic agents. Here we review studies which evaluate lysosomal changes in the liver following administration of lysosomotropic agents to experimental animals, and relate them to toxic side‐effects or pharmacological action, as was suggested by de Duve et al. (1974). Common features of lysosomal changes include, the overload of liver lysosomes by non‐digestable material; increased size and number of liver lysosomes; inhibition of several lysosomal enzymes; secondary increase in the activity of some lysosomal enzymes; increased autophagy, and fusion disturbances. There was no significant change in endocytosis, except for an increase in the Triton WR 1339 model. Microsc. Res. Tech. 36:253–275, 1997. © 1997 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/(SICI)1097-0029(19970215)36:4<253::AID-JEMT4>3.0.CO;2-N
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000E00
- to stream Istex, to step Curation: 000E00
- to stream Istex, to step Checkpoint: 001757
- to stream Main, to step Merge: 002A12
- to stream Main, to step Curation: 002962
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals</title><author><name sortKey="Schneider, Peter" sort="Schneider, Peter" uniqKey="Schneider P" first="Peter" last="Schneider">Peter Schneider</name></author><author><name sortKey="Korolenko, Tatjana A" sort="Korolenko, Tatjana A" uniqKey="Korolenko T" first="Tatjana A." last="Korolenko">Tatjana A. Korolenko</name></author><author><name sortKey="Busch, Ulrich" sort="Busch, Ulrich" uniqKey="Busch U" first="Ulrich" last="Busch">Ulrich Busch</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:242096BBBEF6C057C428142DAA15F59AE79C8453</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1002/(SICI)1097-0029(19970215)36:4<253::AID-JEMT4>3.0.CO;2-N</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-QWLMS9KB-R/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000E00</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E00</idno><idno type="wicri:Area/Istex/Curation">000E00</idno><idno type="wicri:Area/Istex/Checkpoint">001757</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001757</idno><idno type="wicri:doubleKey">1059-910X:1997:Schneider P:a:review:of</idno><idno type="wicri:Area/Main/Merge">002A12</idno><idno type="wicri:Area/Main/Curation">002962</idno><idno type="wicri:Area/Main/Exploration">002962</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals</title><author><name sortKey="Schneider, Peter" sort="Schneider, Peter" uniqKey="Schneider P" first="Peter" last="Schneider">Peter Schneider</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Hermann‐Volz‐Str. 77, D‐88400 Biberach</wicri:regionArea><wicri:noRegion>88400 Biberach</wicri:noRegion><wicri:noRegion>D‐88400 Biberach</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Correspondence address: Hermann‐Volz‐Straße 77 D‐88400 Biberach</wicri:regionArea></affiliation></author><author><name sortKey="Korolenko, Tatjana A" sort="Korolenko, Tatjana A" uniqKey="Korolenko T" first="Tatjana A." last="Korolenko">Tatjana A. Korolenko</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Institute of Physiology, Siberian Branch Academy of Medical Science, Novosibirsk</wicri:regionArea><wicri:noRegion>Novosibirsk</wicri:noRegion></affiliation></author><author><name sortKey="Busch, Ulrich" sort="Busch, Ulrich" uniqKey="Busch U" first="Ulrich" last="Busch">Ulrich Busch</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Köhlesrain 87/4 D‐88400 Biberach</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Microscopy Research and Technique</title><title level="j" type="alt">MICROSCOPY RESEARCH AND TECHNIQUE</title><idno type="ISSN">1059-910X</idno><idno type="eISSN">1097-0029</idno><imprint><biblScope unit="vol">36</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="253">253</biblScope><biblScope unit="page" to="275">275</biblScope><biblScope unit="page-count">23</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1997-02-15">1997-02-15</date></imprint><idno type="ISSN">1059-910X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1059-910X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="fr">Lysosomotropic agents are selectively taken up into lysosomes following their administration to man and animals [de Duve et al. (1974) Biochem. Pharmacol. 23:2494–2531] The effects of lysosomotropic drugs studied in vivo and in vitro can be used as models of lysosomal storage diseases. These agents include many drugs still used in clinical medicine: aminoglycosides used in antibiotics [Tulkens (1988)]; phenothiazine derivatives; such antiparasitic drugs as chloroquine and suramin; antiinflammatory drugs like gold sodium thiomalate; and cardiotonic drugs like sulmazol [Schneider (1992) Arch. Toxicol. 66:23–33]. Side‐effects to these drugs can be caused by their lysosomotropic properties. In addition to drugs, other compounds to which man and animals are exposed (e.g., metals, cytostatics, vitamins, hormones) are also lysosomotropic. Liver cells, especially Kuppfer cells, are known to accumulate lysosomotropic agents. Here we review studies which evaluate lysosomal changes in the liver following administration of lysosomotropic agents to experimental animals, and relate them to toxic side‐effects or pharmacological action, as was suggested by de Duve et al. (1974). Common features of lysosomal changes include, the overload of liver lysosomes by non‐digestable material; increased size and number of liver lysosomes; inhibition of several lysosomal enzymes; secondary increase in the activity of some lysosomal enzymes; increased autophagy, and fusion disturbances. There was no significant change in endocytosis, except for an increase in the Triton WR 1339 model. Microsc. Res. Tech. 36:253–275, 1997. © 1997 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Russie</li></country></list><tree><country name="Allemagne"><noRegion><name sortKey="Schneider, Peter" sort="Schneider, Peter" uniqKey="Schneider P" first="Peter" last="Schneider">Peter Schneider</name></noRegion><name sortKey="Busch, Ulrich" sort="Busch, Ulrich" uniqKey="Busch U" first="Ulrich" last="Busch">Ulrich Busch</name><name sortKey="Schneider, Peter" sort="Schneider, Peter" uniqKey="Schneider P" first="Peter" last="Schneider">Peter Schneider</name></country><country name="Russie"><noRegion><name sortKey="Korolenko, Tatjana A" sort="Korolenko, Tatjana A" uniqKey="Korolenko T" first="Tatjana A." last="Korolenko">Tatjana A. Korolenko</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002962 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002962 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:242096BBBEF6C057C428142DAA15F59AE79C8453
|texte= A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals
}}
| This area was generated with Dilib version V0.6.33. |  |